About
Harmony Consulting
Harmony Biotech Consulting is a trusted partner to biotech, pharma, and medical device companies, offering decades of experience and deep expertise across the development spectrum. From early-stage drug development to CMC manufacturing and regulatory strategy, we deliver tailored solutions that drive efficiency, accelerate timelines, and solve complex challenges.
Our flexible consulting and staff augmentation models are designed to integrate seamlessly with your team — offering the right support, right when you need it. Whether you’re navigating a critical regulatory submission or scaling up manufacturing, we adapt to your needs with precision and agility.
At Harmony Biotech Consulting, we don’t just consult — we collaborate. Let us help you move your science forward, faster.
Our Team
Chris Stanley
I bring nearly three decades of experience in the biotech and pharmaceutical industries, specializing in GxP operations, quality systems, validation, and regulatory affairs. As President of Harmony Consulting, I help life science companies—from startups to established manufacturers—build and scale compliant, efficient, and inspection-ready operations.
My expertise spans the full product lifecycle, from development through commercialization, across biologics, sterile injectables, cell therapies, oral solid dosage forms, diagnostics, and combination products. I’ve led technical operations, managed complex vendor networks, and authored high-stakes regulatory submissions, including INDs, BLAs, NDAs, 510(k)s, and Orphan Drug/Fast Track applications.
Throughout my career, I’ve established GMP-compliant systems from scratch, supported successful FDA inspections, and led the strategic validation and remediation of facilities and products. I’ve worked on products ranging from monoclonal antibodies to medical countermeasures, helping clients bring critical therapies to market efficiently and compliantly.
Key strengths include:
- Regulatory Affairs: IND, NDA, BLA, 510(k), Orphan, Fast Track submissions
- GxP Compliance: FDA, EMA, PMDA audit readiness and remediation
- Analytical Method Development & Validation (ELISA, PCR, flow cytometry, etc.)
- Quality Systems: SOPs, batch records, deviations, CAPAs, validation protocols
- Technical Operations: Manufacturing oversight, CMO/CRO management
- FDA-facing Leadership: Regulatory contact for early- and late-stage programs
- Program Management: BARDA-funded and federally supported contracts >$100M
Lisa Stanley
With over 15 years of experience in the pharmaceutical and biotech industry, I specialize in helping companies navigate the complex world of GxP compliance, regulatory strategy, and contract law. As CEO of Harmony Consulting, I’ve supported startups to global organizations by building quality systems from the ground up, managing multimillion-dollar funding efforts, and guiding legal and regulatory documentation through every stage of development.
My background in legal affairs uniquely positions me to bridge the gap between science and compliance. I’ve authored and reviewed thousands of SOPs, contracts, technical reports, and FDA submissions. I’m especially passionate about ensuring that biotech companies are not only compliant—but also investor- and inspection-ready.
At Harmony, I combine strategic oversight with hands-on support, offering biotech clients a trusted partner in compliance, growth, and operational excellence. Let’s connect if you’re looking for expertise in regulatory compliance, legal affairs, or biotech business development.
Notable areas of expertise:
- GxP documentation & quality systems
- Regulatory submissions (pre-IND, IND, EOP2)
- Legal contract negotiation & review (supply, quality, confidentiality, partnership)
- Grant writing for NIH, DOD, DARPA & other agencies
- Business development & operational leadership
